CLINICAL CORRELATIONS

Slides:



Advertisements
Similar presentations
Distinctive characteristics
Advertisements

1 Infer How do genetic disorders such as CF support the theory of evolution 2 Review Explain two sex chromosome disorders 3 Description Write a paragraph.
Prions MICR 401 Group 8: Ben Saiyasombat 10/30/2012 Department of Biology and Microbiology.
PRIONS Defn: small proteinaceous infectious particles that resist inactivation by procedures that modify viruses and nucleic acids.
Mouse Prion Protein Domain PrP( ) Andreas Razen Geometric Computations in Molecular Biology 2 May 2007.
The Role of Beta Amyloid proteins in Alzheimer’s Disease What is A.D.?
PHL 437/Pharmacogenomics Fourth Lecture (Parkinson’s disease) By Abdelkader Ashour, Ph.D. Phone:
L and D isomers of amino acids. Ionization state as a function of pH.
CLINICAL ASPECTS OF BIOCHEMISTRY NEURODEGENERATIVE DISEASES Prion diseases Alzheimer's disease.
Disorders caused by pathological conformation of proteins
(Foundation Block) Dr. Ahmed Mujamammi Dr. Sumbul Fatma
Protein-Misfolding Diseases PHY6940 April 8 th 2009 Jessica Nasica.
Prion Diseases Microbes and Society Fall What is a Prion? Prion- small proteinaceous infectious particles which resist inactivation by procedures.
A view into Neurodegeneration and neurodegenerative diseases Bahareh Eftekharzadeh Laboratory of Dr. Xavier Salvatella SemesterI Crazy about Biomedicine.
Chapter 21. Molecular Mechanisms of Neurological Disease Copyright © 2014 Elsevier Inc. All rights reserved.
Genes as DNA: How Genes Encode Proteins
Holly Allen CREUTZFELDT-JAKOB DISEASE.  Human equivalent of mad cow disease  Rare, degenerative, fatal disease  Approximately 1 case per million per.
BIOCHEMISTRY DR AMENA RAHIM. Structure of Elastin It is a connective tissue protein Rubber like properties Elastin & glycoprotein microfibrils are present.
How do proteins fold? Folding in a test-tube The structure of proteins is determined by the amino acid sequence; many proteins in solution can be unfolded.
Alzheimer Disease By Ashley Wallace. Facts Discovered by Alois Alzheimer in 1907Discovered by Alois Alzheimer in /3 or more of all diagnosed cases.
By : Amirah nu’aimi Sharifah Nurul Hanim TASK 2 – DISCUSS THE EXAMPLE OF PROTEIN FOLDING DISEASE BY STATING THE MECHANISM.
Introduction Alzheimer’s disease (AD) is a neurodegenerative disease associated with brain shrinkage and the loss of neurons, particularly cholinergic.
Nervous System Transmission of Nerve Signals for  Communication  Coordination and Regulation of Body Systems.
Active Transport. Cellular energy is used to to transport substances across the membrane against a concentration gradient Energy is derived from splitting.
Protein Misfolding Can Have Deadly Consequences Yu Tiantian Li Yihan.
14.2 Human Genetic Disorders
PRIONS Kalina Estrada TA: Yu-Chen Hwang Thursday, 7-8pm.
PROTEINS BY DR. MARYJANE. INTRODUCTION Proteins are macromolecules formed of amino acids united together by peptide bonds.
----protein folding can have deadly consequences
Chapter 14: Human Inheritance
Advances in polyglutamine disease research & therapy
PRIONS 221.
Characterizing and Classifying Viruses, Viroids, and Prions.
Protein conformational disorders Amyloid Alice Skoumalová.
Bioinformatics: Practical Application of Simulation and Data Mining Protein Aggregation I Prof. Corey O’Hern Department of Mechanical Engineering & Materials.
Under the supervision of miklós jászberényi
Α-synuclein transgenic mouse models of Parkinson’s disease Michelle Maurer December 2015.
Lesson Overview Lesson Overview Human Genetic Disorders From Molecule to Phenotype How do small changes in DNA molecules affect human traits? Changes in.
Protein Related Diseases
Lesson Overview 14.2 Human Genetic Disorders. THINK ABOUT IT Have you ever heard the expression “It runs in the family”? Relatives or friends might have.
Prion diseases (transmissible spongiform encephalopathies) Dr. Mohammad Shakeeb, MD Specialist in clinical pathology/Microbiology and immunology.
CLINICAL CORRELATIONS
Protein Folding.
UNIT I: Protein Structure and Function
Biochemistry Free For All
Human Genetic Mutations
Catabolism of amino acid nitrogen
(Bovine spongiform encephalopathy)
Protein conformational disorders
Protein Folding Diseases
14.2 Human Genetic Disorders
Proteins Primary structure: Amino acids link together to form a linear polypeptide. The primary structure of a protein is a linear chain of amino acids.
CLINICAL CORRELATIONS
Alzheimer’s Disease Dr. Usman Ghani CNS Block.
Petra Jenišová Veronika Plačková Magdaléna Trojanová
Alzheimer’s Disease CNS Block.
Protein conformational disorders
Protein structure (Foundation Block) Dr. Sumbul Fatma
Unit 40 Dementia care.
14.2 Human Genetic Disorders
Investigations into Prionic Mutations Mutated Prion Protein (PrPSc)
III. Parkinson Disease.
Alpha-synuclein in Parkinson's disease
Rabies virus and Prion Dongli Pan
Inherited Metabolic Disorders
Deadly Conformations—Protein Misfolding in Prion Disease
The Ubiquitin Proteasome System in Neurodegenerative Diseases
Alzheimer’s Disease Dr. Usman Ghani Neuropsychiatry Block.
Protein structure (Foundation Block).
Protein structure (Foundation Block).
Presentation transcript:

CLINICAL CORRELATIONS PROTEIN MISFOLDING CLINICAL CORRELATIONS

Protein misfolding Every protein must fold to achieve its normal conformation and function. Abnormal folding of proteins leads to a number of diseases in humans.

Role of chaperons in protein folding: Chaperons are a specialized group of proteins, required for the proper folding of many species of proteins. They also known as “heat shock” proteins. The interact with polypeptide at various stages during the folding process.

• Folding means arriving at the right combinations of angles for every amino acid residue in the sequence. • Proteins fold on a defined pathway (or a small number of alternative pathways); they don't randomly search all possible conformations until they arrive at the most stable (lowest free energy) structure. • Proteins that don't (re)fold on their own, need "molecular chaperones" (which are also proteins) to keep them from slipping off the folding pathway or to help them to get back on it. –Some chaperones require ATP to carry out their function.

MANY DISEASES ARE THE RESULT OF DEFECTS IN PROTEIN FOLDING. • Examples: – CYSTIC FIBROSIS involves misfolding and resulting in lack of a protein involved in Cl– transport across membranes. – MANY NEURODEGENERATIVE DISORDERS INVOLVE ABNORMAL PROTEIN AGGREGATION. • PRION DISEASES (e.g., CJD, Creutzfeldt-Jakob disease) = spongiform encephalopathies (also includes “mad cow” disease, scrapie in sheep, etc.) • Alzheimer disease • Parkinson Disease • Huntington Disease • PARTLY FOLDED OR MISFOLDED POLYPEPTIDES OR FRAGMENTS may sometimes associate with similar chains to form aggregates. • Partial unfolding of correctly folded proteins may also lead to aggregation. • Aggregates vary in size from soluble dimers and trimers up to insoluble fibrillar structures (amyloid). AMYLOIDOSIS

OTHER DISEASES INVOLVING ABNORMAL FOLDING/AGGREGATION OF OTHER PROTEINS • HUNTINGTON DISEASE (a "polyglutamine disease", trinucleotide expansion disorder) – Hereditary: autosomal dominant allele, caused by mutation that‘s an expansion (abnormal lengthening) of repeated sequence CAGCAGCAG… in gene for the protein huntingtin, encoding polyGln sequences in the protein. – Huntington disease affects about 1 in 10,000 people in general population -- late onset (middle age), but longer triplet expansions seem to cause earlier onset of more rapidly progressing disease (due to the more highly aggregation-prone mutant protein with longer polyGln sequences) – Protein aggregates accumulate in nuclei and cytoplasm of neurons in striatum region of the brain, which is required for coordinated movements, ultimately killing the neurons. – Disease leads to rigidity and dementia, always fatal. – Other trinucleotide expansion diseases, e.g., spinocerebellar ataxias.

CYSTIC FIBROSIS • defective protein = CFTR (Cystic Fibrosis Transmembrane conductance Regulator) • LACK of normal protein, not the abnormal protein itself, causes disease. • Normal protein is a membrane protein (an ATP-regulated chloride channel) in plasma membranes of epithelial cells, that pumps Cl– ions OUT of cells • Defective (mutant) protein doesn’t fold properly. • Folding intermediates don't dissociate from chaperones, preventing CFTR from insertion into membrane. • High intracellular Cl– concentration makes cells take up H2O from surrounding mucus by osmosis. • Thick mucus accumulates in lungs and other tissues, and its presence in lungs causes difficulty breathing and makes affected individuals very subject to infections like pneumonia.

HUMAN NEURODEGENERATIVE DISORDERS e.g., PRION DISEASES like Creutzfeldt-Jakob Disease (CJD), Alzheimer Disease, Parkinson Disease, Huntington Disease • formation of protein aggregates, amyloid plaques/tangles, lesions in the brain (Other amyloid-forming diseases affect other organs, e.g., liver or heart). • Fibrils resulting from aggregation of different proteins (different diseases) have common structural feature: central core of β sheets known as a "cross-beta" structure.

SPONGIFORM ENCEPHALOPATHIES e.g., scrapie (sheep), kuru (humans), bovine spongiform encephalopathy (BSE, "mad cow disease"), scrapie (sheep), kuru (humans), Hypothesis: misfolded proteins in all kinds of cells are always forming cross-beta structures, but most cell types have adequate degradative machinery to clean up the "garbage" so it doesn't accumulate. Maybe neurons lack adequate molecular machinery to dispose of them. Abnormal protein can be acquired by infection, or by inheritance (dominant), or spontaneously ("sporadic" -- unknown cause).

(SPONGIFORM ENCEPHALOPATHIES, continued) • A tiny bit of ABNORMALLY folded protein, PrPSC, can aggregate to form “cross-beta” structures, and small aggregates ("nuclei") can shift folding of normal proteins to join the aggregation process and adopt the abnormal conformation • In a sort of cascading "domino effect", a high concentration of abnormally folded protein (PrPSC) forms amyloid plaques (large insoluble fibrous aggregates with β conformation prevalent) in brain. • These cross-beta structures fortunately don't form very fast, but if concentration of the aggregation-prone intermediates increases, rate of cross-beta formation can increase dramatically.

Creutzfeldt-Jacob or prion disease: Prion protein is present in normal brain tissue.In diseased brains, the same protein is misfolded. It, therefore, forms insoluble fibrous aggregates that damage brain cells. • Fatal, neurodegenerative diseases, with characteristic "holes" appearing in brain ("sponge"-like appearance) • Infectious, but causative agent is an abnormal protein, a "prion” ("proteinaceous infectious only" protein, PrP) (Stanley Prusiner, Nobel Prize in Physiology/Medicine 1997). 1. Transmissible agent: various sized aggregates of a specific protein 2. Aggregates are resistant to treatment by most protein-degrading enzymes. 3. Protein is largely or completely derived from a cellular protein, PrP, (PrPC) normally present in brain. 4. PrPC has a lot of α-helical conformation; abnormal conformation, PrPSC, has much more β conformation, that tends to aggregate with other PRP molecules.

Alzheimer Disease : β amyloid protein is a misfolded protein. Protein misfolding Alzheimer Disease : β amyloid protein is a misfolded protein. It forms fibrous deposits or plaques in the brains of Alzheimer’s patients. • Symptoms: memory loss, dementia, impairment in other forms of cognition and behavior • Not transmissible between individuals • Intracellular aggregates (fibrillar tangles) of protein called tau • Extracellular plaques contain aggregates of β-amyloid peptides (Aβ):40-42-residue segments derived by proteolytic cleavage of a much larger protein (amyloid precursor protein, APP) attached to plasma membrane of neurons (function unknown)

OTHER DISEASES INVOLVING ABNORMAL FOLDING/AGGREGATION OF OTHER PROTEINS • PARKINSON DISEASE – Protein that forms fibrils is α-synuclein. – Lesions ("Lewy bodies") form in cytosol of dopaminergic neurons in substantia negra of brain, accompanied by muscle rigidity and resting tremor.

In the brain, alpha-synuclein is found mainly at the tips of nerve cells (neurons) in specialized structures called presynaptic terminals. Within these structures, alpha-synuclein interacts with phospholipids and proteins. Presynaptic terminals release chemical messengers, called neurotransmitters, from compartments known as synaptic vesicles. The release of neurotransmitters relays signals between neurons and is critical for normal brain function. Although the function of alpha-synuclein is not well understood, studies suggest that it plays a role in maintaining a supply of synaptic vesicles in presynaptic terminals by clustering synaptic vesicles. It may also help regulate the release of dopamine, a type of neurotransmitter that is critical for controlling the start and stop of voluntary and involuntary movements